India's first indigenous vaccine 'Covaxin' gets expert panel's nod | Bharat Biotech | World News

(1:25)

Covaxin gets WHO's nod; here's what it will mean for those who have taken the shot | World News

(8:3)

Covid-19 Vaccine Covishield, Covaxin Gets Final Approval From DCGI's Expert Panel | Breaking News

(2:31)

Covaxin Gets WHO Approval, Finally

(2:47)

Bharat Biotech’s COVAXIN gets nod for phase 2/3 trials on 2-18 years old | Latest English News

(3:25)

Covid-19 Vaccine For Kids | Covaxin Gets Approval For Phase 2-3 Clinical Trials For 2-18 Age Group

(4:50)

India's Covishield \u0026 Covaxin Gets DGCI Nod, Here's Everything You Need To Know| India Today

(25:9)

Bharat Biotech’s Covid-19 vaccine Covaxin gets WHO’s emergency use approval | Oneindia News

(1:50)

Hunt For Vaccine: India's First Coronavirus Vaccine Candidate 'Covaxin' Gets Nod For Human Trials

(3:33)

India's First COVID Vaccine Covaxin Gets DCGI Nod For Human Trials

(8:3)

Relief For Parents As Covaxin Gets Emergency Use Approval For Kids Aged 2-18 Years | 6 PM Prime

(12:8)

Vivek Ramaswamy Resigns As Co-head Of DOGE, Is Elon Musk To Blame? | India Global

(2:38)

Immigrant Activist Ravi Ragbir Speaks After Biden's Last-Minute Pardon Saved Him from Deportation

(12:39)

Guilbeault open to abandoning carbon tax as he endorses Carney | Power Panel

(7:47)

Pfizer CEO Discusses New Administration with CNBC

(8:5)

Saif Ali Khan Attack: Vice President Dhankar Warns Of 'Unmanageable' Illegal Migration In India

(4:14)

Bharat Biotech’s 'Covaxin' gets SEC nod for phase 2-3 clinical trials on 2 to 18 year-olds

(2:18)

Covaxin gets nod for trials on children above 12 years | Oneindia News

(1:15)

Covid vaccine: Mumbai firm gets approval to make Covaxin; 2 crore jabs/month aim

(1:48)

Bharat Biotech's Covaxin Gets Approval For Emergency Use In India | India Today Milan Sharma Reports

(9:26)

Covaxin Gets Approval For Emergency Use For Children Aged 12, Above | Breaking News

(3:6)

Covaxin Gets Emergency Use Approval For Kids: FAQs Answered | COVID Vaccine News | CNN News18 LIVE

(16:45)

India's Indigenous Covid Vaccine Covaxin Gets WHO's Emergency Use Approval | Vaccination Drive

(33:43)

Covaxin Gets Emergency Use Approval For Kids Aged 2-18 Years | Breaking News

(11:55)

Bharat Biotech's Covaxin gets Subject Expert Committee (SEC) approval for emergency use

(8:50)